Hepcidin and Iron Absorption in Athletes: Why Timing Your Iron Supplement Matters
Table of Contents
Introduction
Iron deficiency is one of the most prevalent nutritional problems in sport — yet many of my patients who diligently take iron supplements are unknowingly undermining their own treatment. Not because the supplement is wrong, but because of when they take it.
A few athletes are aware that a liver-produced hormone called hepcidin governs how much iron the gut can absorb — even though exercise causes it to spike precisely when most take their supplements. Understanding this hormonal window is one of the most practical and underused tools in sports nutrition. Understanding the relationship between hepcidin and iron absorption in athletes is key to solving this problem.
Iron Deficiency in Athletes and Its Link to Iron Absorption
Iron deficiency is disproportionately common in athletes, especially endurance athletes and female athletes. Studies suggest that roughly 15–35% of female athletes and 5–11% of male athletes may be affected, with endurance athletes at particularly elevated risk [1]. In female athletes specifically, a 2025 systematic review of 23 studies comprising 669 athletes across 16 sports found that up to 60% experience iron deficiency at some point in their competitive careers [2].
The performance consequences are measurable. The same systematic review found that iron deficiency can impair endurance performance and maximal aerobic capacity in female athletes [2]. In sports where fractions of a percent determine podium positions, this impairment is clinically significant. Iron deficiency also affects markers that extend well beyond the classic hemoglobin picture — for a full overview of which blood tests actually capture this in athletes, see Which Blood Tests Do Athletes Actually Need? and for the specific iron panel, Iron Panel Interpretation for Athletes.
Multiple mechanisms drive this iron drain: increased losses through sweat, foot-strike hemolysis, gastrointestinal microischemia during hard training, and menstrual blood loss in female athletes. But one mechanism is particularly insidious because it directly undermines the most common treatment strategy — daily iron supplementation timed around training.
Hepcidin — and its role in iron regulation — remains relatively underrecognized in general clinical practice, particularly among clinicians who do not specialize in sports physiology. It is rarely emphasized in medical training and is not typically part of routine clinical focus, as highly active or elite-level athletes make up a relatively small proportion of most patient populations.
Hepcidin and Iron Absorption in Athletes: Why Exercise Matters
Hepcidin is a 25-amino acid peptide hormone synthesized in the liver that functions as the master regulator of systemic iron homeostasis. Its primary mechanism is the degradation of ferroportin — the sole cellular iron export channel — on intestinal enterocytes and macrophages. When hepcidin rises, ferroportin is internalized and degraded, iron remains trapped inside intestinal cells, and dietary and supplemental iron absorption from the gut falls sharply.
Under normal resting conditions, hepcidin follows an innate diurnal rhythm, with concentrations lowest in the early morning and rising progressively throughout the day[3]. Research has confirmed this circadian pattern is driven by internal timing mechanisms rather than by dietary iron intake itself[3].
Exercise adds a second, more powerful hepcidin stimulus on top of this baseline. During moderate-to-high intensity training, working skeletal muscle releases the cytokine interleukin-6 (IL-6) in large quantities. In a landmark study by Peeling and colleagues, a 60-minute high-intensity run produced a 6.9-fold increase in IL-6 immediately post-exercise, followed by a 2.6-fold increase in C-reactive protein at 24 hours [4]. Hepcidin concentrations then rose 1.7–3.1 times above baseline at 3, 6, and 24 hours post-run, with 3-hour post-run values 3.0 times greater than the corresponding rest-trial values [4]. The broader post-exercise inflammatory pattern — including the CRP and IL-6 responses — is covered in clinical depth in Inflammation Markers in Athletes: CRP and Recovery and Endurance Athlete Blood Ranges.
From an evolutionary perspective, the primary function of hepcidin is to regulate iron availability as part of the body’s defense against infection. By reducing iron absorption from the gut and trapping iron within cells, hepcidin limits circulating iron available to pathogens, many of which depend on iron for growth. Most bacteria require iron for essential metabolic processes, including energy production and DNA synthesis. Because of this, limiting iron availability is an effective way for the body to inhibit bacterial growth. This same response is also reflected in rising ferritin levels, as iron is increasingly stored within cells rather than circulating in the bloodstream.
One possible explanation — and one that I find particularly plausible — is that, historically, periods of intense physical exertion were associated with an increased risk of trauma and pathogen exposure. In this context, the hepcidin response may have evolved as a protective mechanism, restricting iron availability during times of heightened vulnerability to infection.
How Hepcidin Affects Iron Absorption in Athletes
A 2023 individual participant data meta-analysis confirmed that exercise is consistently associated with a 1.5–2.5-fold increase in hepcidin concentrations peaking between 3 and 6 hours post-exercise[5]. Pre-exercise hepcidin concentration accounted for approximately 44% of the variance in 3-hour post-exercise hepcidin levels, with other athlete and exercise characteristics contributing smaller additional effects[5]. In practical terms, the magnitude of the hepcidin response is influenced by pre-exercise hepcidin levels, which are themselves affected by factors such as iron status.
Crucially, this hepcidin surge translates directly into measurable reductions in iron absorption. A 2022 clinical trial by Barney and colleagues assigned 28 trained collegiate cross-country runners to consume an iron-labeled meal 2 hours after a prolonged run (approximately 99 minutes, 21 km) or after a matched rest period. Plasma hepcidin increased 51% following exercise compared with rest. Fractional iron absorption — measured by tracking isotope incorporation into red blood cells 15 days later — was reduced by 36% in the post-run condition (11.8% versus 18.5% at rest) [6].
In practical terms, patients can be told that the hepcidin response alone may reduce iron absorption by roughly one-third — which is often clinically significant in individuals who are already iron deficient. This becomes particularly important in female patients, especially those with heavy menstrual bleeding, as well as in individuals following vegetarian diets or those with generally low dietary iron intake.
Does Timing of Exercise Matter? Morning vs. Afternoon
Because hepcidin naturally rises across the day, afternoon training sessions create a compounded hepcidin environment: elevated baseline from the circadian pattern, plus the additional post-exercise surge.
McCormick and colleagues tested this directly in 16 endurance-trained runners with serum ferritin below 50 µg/L, completing identical 90-minute runs in either the morning or afternoon in a crossover design [7]. During the afternoon trial, hepcidin concentrations were already elevated from diurnal accumulation before exercise began, and rose a further 0.68 nM (P < 0.001) in the 3 hours post-run [7]. Fractional iron absorption was significantly greater after the morning run when iron was consumed within 30 minutes of exercise cessation — higher than both the rested condition and the post-afternoon-run condition [7].
Interestingly, iron absorption in this early post-exercise window was preserved and even appeared higher than at rest. While the mechanism is not fully clear, this suggests that taking iron immediately after training is not detrimental — whereas delaying intake by several hours may reduce absorption due to rising hepcidin levels.
The data suggest that morning exercise followed by iron consumption before the 3-hour hepcidin peak may be advantageous for iron-deficient athletes, though real-world scheduling constraints are significant and the broader evidence base continues to develop. Athletes managing persistent iron deficiency should also ensure their ferritin is being evaluated with athlete-specific thresholds — see Ferritin Levels for Athletes for a detailed breakdown of why “normal” is not the same as optimal for a competitive athlete.
In my practice, I would recommend that athletes take iron supplements in the morning — ideally before training if tolerated. Iron absorption tends to be higher earlier in the day and is reduced later on, particularly after exercise when hepcidin levels are elevated. For this reason, it is best to avoid evening dosing, especially after training.
Iron Status Modulates the Hepcidin Response
The magnitude of the post-exercise hepcidin response also depends in part on the athlete’s baseline iron stores. Research by Peeling and colleagues examining 54 athletes grouped by baseline serum ferritin found that athletes with ferritin below 30 µg/L showed a blunted post-exercise hepcidin response — a pattern consistent with the body’s iron-sensing system modulating the inflammatory signal in an attempt to maximize iron availability during severe depletion [8]. Athletes with ferritin in the 30–50 µg/L range — suboptimal but not severely depleted — still showed significant post-exercise hepcidin elevations that would impair absorption from poorly timed supplements [8].
To me this is physiologically intuitive: when iron stores are already low, the body appears to prioritize iron availability over strict iron restriction, even if this may come at the expense of optimal pathogen defense. It reflects a finely tuned regulatory balance, where iron metabolism is adjusted dynamically according to physiological need.
Supplement Dosing Schedule: The Alternate-Day Advantage
The hepcidin-timing problem extends beyond exercise. Oral iron doses of ≥60 mg themselves raise serum hepcidin and keep it elevated for approximately 24 hours. A randomized controlled trial by Stoffel and colleagues assigned iron-depleted women to 60 mg of elemental iron daily for 14 days versus the same dose on alternate days for 28 days [9]. The alternate-day group had significantly lower serum hepcidin throughout and achieved a cumulative fractional iron absorption of 21.8% compared to 16.3% in the consecutive-day group (p = 0.0013) — a 34% relative improvement in iron bioavailability from the same total supplement dose [9]. Gastrointestinal side effects also trended lower in the alternate-day group.
The mechanism is straightforward: daily dosing keeps hepcidin persistently elevated, diminishing absorption from each successive dose. Alternate-day dosing allows hepcidin to return toward baseline in the 48-hour inter-dose window, restoring gut responsiveness to each tablet. When oral supplementation is not achieving the expected ferritin response — particularly in athletes with iron deficiency anemia or those facing an imminent competition window — covers when parenteral iron is clinically appropriate and how it bypasses the hepcidin-mediated gut barrier entirely.
When oral supplementation does not produce the expected ferritin response — particularly in athletes with iron deficiency anemia — parenteral iron may be clinically appropriate, as it bypasses the hepcidin-mediated limitations of intestinal absorption.
In practice, some patients consider intravenous iron as an alternative. However, the clinical criteria for IV iron should not differ from standard indications. Being an athlete — or having upcoming competitions — is not, in itself, a justification for iron infusion. Parenteral iron is reserved for the treatment of confirmed iron deficiency under specific clinical criteria, which are discussed in detail in my article on IV Iron for Athletes.
Dietary Strategies to Support Iron Absorption
Beyond supplement timing, the composition of the iron-containing meal matters. Non-heme iron — found in plant foods, fortified cereals, and eggs — is substantially more sensitive to dietary co-factors than heme iron from meat. Vitamin C (ascorbic acid) is the most potent known dietary enhancer of non-heme iron absorption. It works by reducing ferric (Fe³⁺) to ferrous (Fe²⁺) iron — the form transportable by intestine— and forming soluble iron chelates that remain bioavailable at the alkaline pH of the duodenum[10]. The practical benefit is greatest when vitamin C is consumed simultaneously with the iron-containing meal, though evidence that long-term vitamin C supplementation substantially changes hemoglobin or ferritin outcomes at a population level is more limited.
In my practice, I often advise patients — if they are not following a specific competition diet or a vegetarian diet — to increase their intake of heme iron sources, such as red meat (including beef, lamb, and game like venison or reindeer), alongside iron supplementation. Fish can be a healthy part of the diet, but it generally contains less iron and is less effective for correcting iron deficiency.
Conclusion
Iron deficiency in athletes is often approached as a question of intake — but in practice, it is just as much a question of timing. Hepcidin creates a predictable, physiology-driven window in which iron absorption is either optimized or significantly impaired. Ignoring this window can mean that even well-adherent supplementation produces suboptimal results.
In my clinical experience, small adjustments — such as taking iron in the morning, avoiding supplementation in the hours following exercise, and considering alternate-day dosing — can make a meaningful difference in restoring iron stores. At the same time, dietary strategies and appropriate patient selection for treatment remain essential, particularly in higher-risk groups such as female athletes.
Ultimately, iron metabolism reflects a finely regulated balance between physiological need and protective mechanisms. Understanding this balance allows clinicians and athletes to move beyond trial-and-error supplementation and toward a more targeted, evidence-informed approach to iron deficiency.
References
- https://doi.org/10.1007/s00421-019-04157-y
- https://doi.org/10.1016/j.jshs.2024.101009
- https://pubmed.ncbi.nlm.nih.gov/23232066/
- https://doi.org/10.1123/ijsnem.19.6.583
- https://doi.org/10.1007/s40279-023-01874-5
- https://doi.org/10.1093/jn/nxac129
- https://doi.org/10.1249/MSS.0000000000002026
- https://doi.org/10.1371/journal.pone.0093002
- https://doi.org/10.1016/S2352-3026(17)30182-5
- https://pubmed.ncbi.nlm.nih.gov/6940487/
- https://doi.org/10.1093/ajcn/nqaa289
